Drug / Pharmaceutical / Medical Device Liability
Many people in the United States each day are hospitalized or killed because of adverse reactions to prescription drugs or because of injuries caused by defective medical devices. Even pharmaceuticals and medical devices that have been approved by the FDA can have side effects that were not detected in pre-approval clinical trials or can have adverse reactions when prescribed by a physician for a contemplated, off-label use.
Levin, Fishbein, Sedran & Berman is a powerhouse in the area of drug, medical device and pharmaceutical liability litigation and recalls, coordinating often parallel state and federal cases for individuals, class actions and in Multidistrict Litigation.
These cases frequently involve the production of millions of pages of information that must be reviewed, sorted and evaluated in order to understand the complex science that is associated with FDA approval processes relevant to the release of a prescription drug or medical device. These cases also require the assembly of respected experts to assist in the litigation.
The firm has the skill to effectively manage these cases and has contacts with experts in order to undertake the daunting task that pharmaceutical and drug/medical device recall litigation involves.
Arnold Levin was appointed to the Negotiating Plaintiff's Counsel committee in the Vioxx litigation, which is the committee that was responsible for negotiating the nationwide settlement for all users of Vioxx that suffered heart attacks, strokes and sudden cardiac deaths.
The firm is currently serving as lead class and liaison counsel in the 600,000 member nationwide Diet Drug Product Liability Litigation class action case, and has represented clients in the Orthopedic Bone Screws Product Liability Litigation, the Rezulin Products Liability Litigation, the Propulsid Products Liability Litigation, the Sulzer Hip Replacement Litigation, the Dalkon Shield Litigation, the Silicone Breast Implant Litigation and the PPA Products Liability Litigation. Each of these cases has required unwavering commitment by the firm to its ideals of representing its clients aggressively and ethically, in order to achieve fair litigation results for its clients.